(45 days)
No
The device description and performance studies focus on the mechanical function and drug delivery characteristics of a spacer/holding chamber, with no mention of AI or ML.
Yes
The device, Vortex, is designed to assist patients in delivering aerosol medication from metered dose inhalers, which is a therapeutic purpose.
No
Explanation: The device description and intended use clearly state that Vortex is a spacer/valved holding chamber for delivering aerosol medication with metered dose inhalers. It is a reusable device designed to assist patients with drug delivery, not to diagnose a medical condition.
No
The device description explicitly states it is a reusable device consisting of an aluminum cylinder with elastomeric fittings and a valved mouthpiece, which are physical hardware components.
Based on the provided information, the Vortex device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is "as a spacer/valved holding chamber for use in delivery of aerosol medication with metered dose inhalers." This describes a device used to facilitate the delivery of medication into the body, not to perform tests on samples taken from the body.
- Device Description: The description details a physical device used to hold and deliver aerosolized medication. It does not mention any components or functions related to analyzing biological samples.
- Lack of IVD Characteristics: The document does not mention any of the typical characteristics of an IVD, such as:
- Testing biological samples (blood, urine, tissue, etc.)
- Detecting or measuring substances in biological samples
- Providing diagnostic information based on sample analysis
- Reagents or assays
The Vortex is a medical device, specifically a drug delivery accessory, but it falls outside the scope of In Vitro Diagnostics.
N/A
Intended Use / Indications for Use
Vortex is indicated for use as a spacer/valved holding chamber for use in delivery of aerosol medication with metered dose inhalers.
Product codes
73 CAF
Device Description
Vortex is a new spacer/holding chamber designed to assist patients using metered dose inhalers (MDI) for aerosolized drug delivery. Vortex may provide enhanced drug delivery, ease of use and ability to clean/disinfect the device.
Vortex is a reusable device consisting of an aluminum cylinder with an elastomeric fitting on one end to accept metered dose inhalers and a valved mouthpiece on the other end to interface with the patient. The elastomeric fitting may be removed for cleaning and/or replacement.
Vortex will be available as a stand-alone item and will also be available packaged with a mask.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Non-clinical Test Summary:
Testing to compare Vortex to Aerochamber was conducted. Characteristics evaluated include:
- Drug delivery (per FDA guidance): Respirable drug delivered through Vortex is comparable to . or greater than Aerochamber.
- Fit with MDI elbows: Vortex fit all MDI elbows evaluated. .
- Inhalation and exhalation resistance: Inhalation and exhalation resistance for Vortex is comparable . to or less than Aerochamber. All results are less than 250 pascal at 30 lpm flow.
Clinical Performance Summary:
Clinical testing was not completed/is not required to show substantial equivalence.
Conclusions from Testing:
Vortex performance is comparable to Aerochamber for all items tested.
Key Metrics
Not Found
Predicate Device(s)
K992917, K930574, K900576, K900557, K884803, K872037, K822437
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 868.5630 Nebulizer.
(a)
Identification. A nebulizer is a device intended to spray liquids in aerosol form into gases that are delivered directly to the patient for breathing. Heated, ultrasonic, gas, venturi, and refillable nebulizers are included in this generic type of device.(b)
Classification. Class II (performance standards).
0
VORTEX 510(k) Submission 510(k) Summary
MAY 0 9 2002
Submitter Information
| Name: | PARI Innovative Manufacturers, Inc. |
|---|---|
| Address: | 13800 Hull Street Road |
| Midlothian, Virginia 23112 | |
| Phone Number: | 804-639-7235 |
| FAX Number: | 804-639-7244 |
| Contact Name: | Lawrence Weinstein |
| Date Prepared: | February 14, 2002 |
Device Name
| Common Name: | Holding Chamber/Spacer |
|---|---|
| Proprietary Name: | Vortex® |
| Classification Name: | Nebulizer (Direct Patient Interface) |
Legally Marketed Predicate Device
Aerochamber Monaghan Medical (and/or Trudell Medical) Plattsburgh, NY
K992917; K930574; K900576; K900557; K884803; K872037; K822437
Device Description
Vortex is a new spacer/holding chamber designed to assist patients using metered dose inhalers (MDI) for aerosolized drug delivery. Vortex may provide enhanced drug delivery, ease of use and ability to clean/disinfect the device.
Vortex is a reusable device consisting of an aluminum cylinder with an elastomeric fitting on one end to accept metered dose inhalers and a valved mouthpiece on the other end to interface with the patient. The elastomeric fitting may be removed for cleaning and/or replacement.
Vortex will be available as a stand-alone item and will also be available packaged with a mask.
Intended Use
ve orex is indicated for use as a spacer/valved holding chamber for use in delivery of aerosol medication with metered dose inhalers.
Technological Characteristics Compared to Predicate Device
Vortex and Aerochamber are both valved holding chambers used to aid in the delivery of MDI v often and released include a cylindrical chamber to allow the MDI drug plume to expand nrior to inhalation by the patient. In addition, both make use of inhalation and exhalation valves to reduce coordination related problems with MDI actuation.
Vortex and Aerochamber make use of thermoplastic components and elastomeric valves and MDI adapters. However, Vortex makes use of a non-electrostatic (anodized aluminum) cylinder to reduce the likelihood of drug deposition on the cylinder.
Non-clinical Test Summary
Testing to compare Vortex to Aerochamber was conducted. Characteristics evaluated include:
- Drug delivery (per FDA guidance): Respirable drug delivered through Vortex is comparable to . or greater than Aerochamber.
- Fit with MDI elbows: Vortex fit all MDI elbows evaluated. .
1
VORTEX 510(k) Submission
510(k) Summary
- Inhalation and exhalation resistance: Inhalation and exhalation resistance for Vortex is comparable . to or less than Aerochamber. All results are less than 250 pascal at 30 lpm flow.
Clinical Performance Summary
Clinical testing was not completed/is not required to show substantial equivalence.
Conclusions from Testing
Vortex performance is comparable to Aerochamber for all items tested.
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" around the perimeter. Inside the circle is an abstract symbol resembling three human profiles facing right, arranged in a stacked formation.
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUN 2 7 2002
Pari Innovative Manufacturers, Inc .. c/o Robert Mosenkis CITECH 5200 Butler Pike Plymouth Metting, PA 19462
K020944 Re:
Vortex Valved Holding Chamber Regulation Number: 868.5630 Regulation Name: Nebulizer Regulatory Class: II (two) Product Code: 73 CAF Dated: April 24, 2002 Received: April 25, 2002
Dear Mr. Mosenkis:
This letter corrects our substantially equivalent letter of May 9, 2002 regarding the indications for use of your device. Our letter incorrectly limited your device to use in military environments.
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your
3
Page 2 - Mr. Robert Mosenkis
device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to continue marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4646. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at their toll free number (800) 638-2041 or at (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html.
Sincerely yours,
Af
Donna-Bea Tillman, Ph.D. Acting Director Division of Cardiovascular and Respiratory Devices Office of Device Evaluation Center for Devices and Radiological Health
4
VORTEX 510(k) Submission Intended Use
D209V4 510(k) Number (if known): {
Device Name: _Vortex™ Valved Holding Chamber
Indications for Use:
Vortex is indicated for use as a spacer/valved holding chamber for use in delivery of aerosol medication with metered dose inhalers.
(PLEASE DO NOT WRITE BELOW THIS LINE- CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use
(per 21 CFR 801.109)
OR
Over-the-Counter Use _________________________________________________________________________________________________________________________________________________________
(Optional Format 1-2-96)
signature
on Douly